Malaria vaccine - AstraZeneca
Latest Information Update: 24 Sep 2021
At a glance
- Originator MedImmune
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 12 Mar 1999 New profile, split from generic Malaria Vaccine profile
- 12 Mar 1999 Discontinued-Unspecified Phase in Malaria in USA (Unknown route)